Dr. Peng Wu is a professor in the Department of Molecular & Cellular Biology at Scripps Research Institute. Dr. Wu received his doctorate from the Scripps Research Institute in 2005 under the guidance of Professor K. Barry Sharpless. From August 2005 to September 2008, he was a postdoctoral fellow in the group of Professor Carolyn R. Bertozzi at the University of California, Berkeley. Dr. Wu's graduate and postdoctoral studies with Prof. Sharpless and Bertozzi laid the foundation for the development of click chemistry and bioorthogonal chemistry. The research in the Wu lab integrates synthetic chemistry with glycobiology to explore the cellular and molecular mechanisms that control immune responses toward cancer and human pathogens. FucoID, a genetic engineering-free labeling technique developed by the Wu lab, provides the first technology to identify the entire repertoire of endogenous tumor antigen-specific T cells for cancer immunotherapy. Dr. Wu was awarded the ACS Horace S. Isbell Award in 2020, the RSC Horizon Prize in 2021 and the SFG Glycobiology Significant Achievement Award in 2021.